chronic ang ii administration Search Results


angpt2  (Multi Sciences (Lianke) Biotech Co Ltd)
93
Multi Sciences (Lianke) Biotech Co Ltd angpt2
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Angpt2, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/Human+Angiopoietin-2%2FANG-2+ELISA+Kit/pm38806553-126-13-14
Average 93 stars, based on 1 article reviews
angpt2 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
chronic infusion of ang ii #015–27911  (FUJIFILM)
90
FUJIFILM chronic infusion of ang ii #015–27911
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Chronic Infusion Of Ang Ii #015–27911, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/chronic+infusion+of+ang+ii++015+27911/pm37983238-69-10-13
Average 90 stars, based on 1 article reviews
chronic infusion of ang ii #015–27911 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ang ii  (Bachem)
90
Bachem ang ii
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Ang Ii, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/ang+ii/pm29895976-261-23-25
Average 90 stars, based on 1 article reviews
ang ii - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ang ii #015–27911  (FUJIFILM)
90
FUJIFILM ang ii #015–27911
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Ang Ii #015–27911, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/ang+ii/pmc10659197-66-10-13
Average 90 stars, based on 1 article reviews
ang ii #015–27911 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ang ii chronic infusion model  (Federation of European Neuroscience Societies)
90
Federation of European Neuroscience Societies ang ii chronic infusion model
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Ang Ii Chronic Infusion Model, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/ang+ii+chronic+infusion+model/pm26700480-28-8-6
Average 90 stars, based on 1 article reviews
ang ii chronic infusion model - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
chronic ang ii administration  (MedChemExpress)
98
MedChemExpress chronic ang ii administration
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Chronic Ang Ii Administration, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/Angiotensin+II+human/pm41796236-39-0-7
Average 98 stars, based on 1 article reviews
chronic ang ii administration - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
quantikine human angiogenin immunoassay  (R&D Systems)
94
R&D Systems quantikine human angiogenin immunoassay
Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and <t>ANGPT2</t> (H) expression in HCC based on the human protein atlas database.
Quantikine Human Angiogenin Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chronic+ang+ii+administration/Human+Angiogenin+Quantikine+ELISA+Kit/pm15182336-1-4-8
Average 94 stars, based on 1 article reviews
quantikine human angiogenin immunoassay - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and ANGPT2 (H) expression in HCC based on the human protein atlas database.

Journal: Scientific reports

Article Title: Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.

doi: 10.1038/s41598-024-62668-x

Figure Lengend Snippet: Figure 10. Mutation landscape analysis and tissue expression of core genes. (A, B) Mutation gene analysis based on whole exome sequencing data in patients with two subtypes of high and low risk. TCGA-LIHC cohort (A), GEO cohort (B). (C) Mutation analysis of three core genes. (D) CNV analysis of three core genes. (E) Differential expression analysis of three core genes in the TCGA-LIHC cohort in cancer and para cancer. (F–H) Validation of NCL (F), SPP1 (G), and ANGPT2 (H) expression in HCC based on the human protein atlas database.

Article Snippet: The levels of NCL (Mlbio, ml038241), IL-10 (Mlbio, ml064299), OPN (Mlbio, ml038278), and ANGPT2 (Multi Sciences, EK1215) were measured using ELISA kits according to the manufacturer’s protocol.

Techniques: Mutagenesis, Expressing, Sequencing, Quantitative Proteomics, Biomarker Discovery

Figure 11. Correlation between signature genes and TME markers in ICI treatment. (A–D) The levels of OPN (A), ANGPT2 (B), NCL (C), and IL-10 (D) in the peripheral blood of patients in the ICI response and ICI resistance groups were measured and then analyzed for differences. (student’s t-test. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001). (E–G) Correlation analysis of IL-10 and OPN (E), ANGPT2 (F), and NCL (G) expression levels in peripheral blood of patients with ICI resistance. (Pearson correlation analysis).

Journal: Scientific reports

Article Title: Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.

doi: 10.1038/s41598-024-62668-x

Figure Lengend Snippet: Figure 11. Correlation between signature genes and TME markers in ICI treatment. (A–D) The levels of OPN (A), ANGPT2 (B), NCL (C), and IL-10 (D) in the peripheral blood of patients in the ICI response and ICI resistance groups were measured and then analyzed for differences. (student’s t-test. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001). (E–G) Correlation analysis of IL-10 and OPN (E), ANGPT2 (F), and NCL (G) expression levels in peripheral blood of patients with ICI resistance. (Pearson correlation analysis).

Article Snippet: The levels of NCL (Mlbio, ml038241), IL-10 (Mlbio, ml064299), OPN (Mlbio, ml038278), and ANGPT2 (Multi Sciences, EK1215) were measured using ELISA kits according to the manufacturer’s protocol.

Techniques: Expressing

Figure 12. Expression levels of SPP1, ANGPT2, and NCL across different cell types. (A–E) The scatter plot demonstrates clustering and grouping results of cells within the LIHC_GSE140228_10X (A) and LIHC GSE140228 Smartseq2 (E). The distribution and expression of target genes SPP1 (B–F), ANGPT2 (C–G), and NCL (D–H) across different cell types.

Journal: Scientific reports

Article Title: Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.

doi: 10.1038/s41598-024-62668-x

Figure Lengend Snippet: Figure 12. Expression levels of SPP1, ANGPT2, and NCL across different cell types. (A–E) The scatter plot demonstrates clustering and grouping results of cells within the LIHC_GSE140228_10X (A) and LIHC GSE140228 Smartseq2 (E). The distribution and expression of target genes SPP1 (B–F), ANGPT2 (C–G), and NCL (D–H) across different cell types.

Article Snippet: The levels of NCL (Mlbio, ml038241), IL-10 (Mlbio, ml064299), OPN (Mlbio, ml038278), and ANGPT2 (Multi Sciences, EK1215) were measured using ELISA kits according to the manufacturer’s protocol.

Techniques: Expressing

Figure 13. Drug–gene interaction and molecular docking analyses. (A–C) Drug–gene interaction network of SPP1 (A), ANGPT2 (B), and NCL (C). (D–F) Molecular docking between three genes and three drugs. SPP1 and Wortmannin (D). ANGPT2 and Ribavirin (E). NCL and Itarnafloxin (F).

Journal: Scientific reports

Article Title: Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.

doi: 10.1038/s41598-024-62668-x

Figure Lengend Snippet: Figure 13. Drug–gene interaction and molecular docking analyses. (A–C) Drug–gene interaction network of SPP1 (A), ANGPT2 (B), and NCL (C). (D–F) Molecular docking between three genes and three drugs. SPP1 and Wortmannin (D). ANGPT2 and Ribavirin (E). NCL and Itarnafloxin (F).

Article Snippet: The levels of NCL (Mlbio, ml038241), IL-10 (Mlbio, ml064299), OPN (Mlbio, ml038278), and ANGPT2 (Multi Sciences, EK1215) were measured using ELISA kits according to the manufacturer’s protocol.

Techniques: